Article, Scientific Insights: Impact on Cost of Care of Concomitant Prescribing of Acid Reducing Agents with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients: A US Payer Perspective

Redirecting in 3 seconds…